Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellinor Bergdahl

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
ESC Heart Failure|January 19, 2018
Eligibility of sacubitril-valsartan in a real-world heart failure population: a community-based single-centre studyHelena Norberg, Ellinor Bergdahl, Krister Lindmark
Cardiovascular Therapeutics|November 28, 2019
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System InhibitorsHelena Norberg, Ellinor Bergdahl, Krister Lindmark
International Psychogeriatrics|January 6, 2011
Depression among the very old with dementiaEllinor Bergdahl, Per Allard, Yngve Gustafson
European Journal of Clinical Pharmacology|January 4, 2020
Differences in medical treatment and clinical characteristics between men and women with heart failure - a single-centre multivariable analysisHelena Norberg, Veronica Pranic, Ellinor Bergdahl, et al.
Cardiovascular Therapeutics|July 19, 2018
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure populationAnna Jonsson, Helena Norberg, Ellinor Bergdahl, et al.
European Journal of Clinical Pharmacology|August 22, 2020
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case studyHelena Norberg, Ellinor Bergdahl, Karin Hellström Ängerud, et al.
International Psychogeriatrics|July 27, 2007
Gender differences in depression among the very oldEllinor Bergdahl, Per Allard, Lena Alex, et al.
Plos One|October 28, 2021
Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal functionAnna Jonsson Holmdahl, Helena Norberg, Fredrik Valham, et al.
The Journal of Vascular Access|July 23, 2025
Patient-related factors influencing the choice of haemodialysis access in SwedenEmelie Laveborn, Ellinor Bergdahl, Ulrika Hahn Lundström, et al.
International Psychogeriatrics|May 19, 2010
One-week prevalence of depressive symptoms and psychotropic drug treatments among old people with different levels of cognitive impairment living in institutional care: changes between 1982 and 2000Hugo Lövheim, Ellinor Bergdahl, Per-Olof Sandman, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
ESC Heart Failure|January 19, 2018
Eligibility of sacubitril-valsartan in a real-world heart failure population: a community-based single-centre studyHelena Norberg, Ellinor Bergdahl, Krister Lindmark
Cardiovascular Therapeutics|November 28, 2019
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System InhibitorsHelena Norberg, Ellinor Bergdahl, Krister Lindmark
International Psychogeriatrics|January 6, 2011
Depression among the very old with dementiaEllinor Bergdahl, Per Allard, Yngve Gustafson
European Journal of Clinical Pharmacology|January 4, 2020
Differences in medical treatment and clinical characteristics between men and women with heart failure - a single-centre multivariable analysisHelena Norberg, Veronica Pranic, Ellinor Bergdahl, et al.
Cardiovascular Therapeutics|July 19, 2018
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure populationAnna Jonsson, Helena Norberg, Ellinor Bergdahl, et al.
European Journal of Clinical Pharmacology|August 22, 2020
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case studyHelena Norberg, Ellinor Bergdahl, Karin Hellström Ängerud, et al.
International Psychogeriatrics|July 27, 2007
Gender differences in depression among the very oldEllinor Bergdahl, Per Allard, Lena Alex, et al.
Plos One|October 28, 2021
Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal functionAnna Jonsson Holmdahl, Helena Norberg, Fredrik Valham, et al.
The Journal of Vascular Access|July 23, 2025
Patient-related factors influencing the choice of haemodialysis access in SwedenEmelie Laveborn, Ellinor Bergdahl, Ulrika Hahn Lundström, et al.
International Psychogeriatrics|May 19, 2010
One-week prevalence of depressive symptoms and psychotropic drug treatments among old people with different levels of cognitive impairment living in institutional care: changes between 1982 and 2000Hugo Lövheim, Ellinor Bergdahl, Per-Olof Sandman, et al.
Pageof 2